A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Subjects with Parkinson's Disease. (SPARK)
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
Biogen, Inc.
Start Date
January 23, 2018
End Date
December 20, 2021
Administered By
Neurology, Movement Disorders
Awarded By
Biogen, Inc.
Start Date
January 23, 2018
End Date
December 20, 2021